Page last updated: 2024-08-16

sb 239063 and sb 242235

sb 239063 has been researched along with sb 242235 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, JL; Boehm, JC; Gallagher, TF; Garigipati, R; Griswold, DE; Hall, R; Kassis, S; Lee, JC; Sorenson, M; Webb, EF1
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1

Other Studies

2 other study(ies) available for sb 239063 and sb 242235

ArticleYear
Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity.
    Bioorganic & medicinal chemistry letters, 2001, Nov-05, Volume: 11, Issue:21

    Topics: Administration, Oral; Animals; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Imidazoles; Lipoxygenase; Liver; Mice; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Pyrimidines; Rats

2001
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011